Your browser doesn't support javascript.
loading
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Freedman, Mark S; Atkins, Harold; Burman, Joachim; Massey, Jennifer; Sutton, Ian; Withers, Barbara; Macdonell, Richard; Grigg, Andrew; Torkildsen, Øivind; Bo, Lars; Lehmann, Anne Kristine; Havrdova, Eva Kubala; Krasulova, Eva; Trnený, Marek; Kozak, Tomas; van der Walt, Anneke; Butzkueven, Helmut; McCombe, Pamela; Skibina, Olga; Lechner-Scott, Jeannette; Willekens, Barbara; Cartechini, Elisabetta; Ozakbas, Serkan; Alroughani, Raed; Kuhle, Jens; Patti, Francesco; Duquette, Pierre; Lugaresi, Alessandra; Khoury, Samia J; Slee, Mark; Turkoglu, Recai; Hodgkinson, Suzanne; John, Nevin; Maimone, Davide; Sa, Maria Jose; van Pesch, Vincent; Gerlach, Oliver; Laureys, Guy; Van Hijfte, Liesbeth; Karabudak, Rana; Spitaleri, Daniele; Csepany, Tunde; Gouider, Riadh; Castillo-Triviño, Tamara; Taylor, Bruce; Sharrack, Basil; Snowden, John A.
Afiliación
  • Kalincik T; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Sharmin S; CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Roos I; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Freedman MS; CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Atkins H; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Burman J; CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Massey J; University of Ottawa, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Sutton I; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Withers B; Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
  • Macdonell R; Department of Neurology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
  • Grigg A; St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Torkildsen Ø; Department of Neurology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
  • Bo L; University of Sydney, Sydney, New South Wales, Australia.
  • Lehmann AK; St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Havrdova EK; Department of Haematology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
  • Krasulova E; Department of Neurology, Austin Health, Melbourne, Victoria, Australia.
  • Trnený M; University of Melbourne, Melbourne, Victoria, Australia.
  • Kozak T; University of Melbourne, Melbourne, Victoria, Australia.
  • van der Walt A; Department of Haematology, Austin Health, Melbourne, Victoria, Australia.
  • Butzkueven H; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • McCombe P; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Skibina O; Department of Haematology, Haukeland University Hospital, Bergen, Norway.
  • Lechner-Scott J; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Willekens B; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Cartechini E; Department of Haematology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Ozakbas S; Department of Haematology, 3rd Faculty of Medicine, Charles University in Prague, and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Alroughani R; Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Kuhle J; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Patti F; Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Duquette P; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Lugaresi A; University of Queensland, Brisbane, Queensland, Australia.
  • Khoury SJ; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Slee M; Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Turkoglu R; Department of Neurology, Box Hill Hospital, Melbourne, Victoria, Australia.
  • Hodgkinson S; Monash University, Melbourne, Victoria, Australia.
  • John N; School of Medicine and Public Health, University Newcastle, Newcastle, New South Wales, Australia.
  • Maimone D; Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, New South Wales, Australia.
  • Sa MJ; Department of Neurology, Antwerp University Hospital, Edegem, Belgium.
  • van Pesch V; Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Gerlach O; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
  • Laureys G; Dokuz Eylul University, Konak, Izmir, Turkey.
  • Van Hijfte L; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
  • Karabudak R; Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
  • Spitaleri D; Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy.
  • Csepany T; Multiple Sclerosis Center, University of Catania, Catania, Italy.
  • Gouider R; CHUM MS Center and Universite de Montreal, Montreal, Quebec, Canada.
  • Castillo-Triviño T; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Taylor B; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Sharrack B; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
  • Snowden JA; Flinders University, Adelaide, South Australia, Australia.
JAMA Neurol ; 80(7): 702-713, 2023 07 01.
Article en En | MEDLINE | ID: mdl-37437240
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Adult / Female / Humans Idioma: En Revista: JAMA Neurol Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Adult / Female / Humans Idioma: En Revista: JAMA Neurol Año: 2023 Tipo del documento: Article País de afiliación: Australia